DiaMedica Therapeutics to Participate in 10th Annual Craig-Hallum Alpha Select Conference
November 05 2019 - 4:04PM
Business Wire
DiaMedica Therapeutics Inc. (Nasdaq: DMAC) today announced that
Rick Pauls, President & Chief Executive Officer, will meet with
institutional investors at the 10th Annual Craig-Hallum Alpha
Select Conference on Tuesday, November 12, 2019, at the Sheraton
New York Times Square Hotel in New York City.
Interested institutional investors should contact their
Craig-Hallum sales representative to schedule a meeting.
About DiaMedica Therapeutics Inc. DiaMedica Therapeutics
Inc. is a clinical stage biopharmaceutical company focused on
developing novel treatments for chronic kidney diseases and
neurological disorders. DiaMedica’s shares are listed on The Nasdaq
Capital Market under the trading symbol “DMAC.”
For more information, please visit www.diamedica.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191105005916/en/
Scott Kellen Chief Financial Officer Phone: (763) 496-5118
skellen@diamedica.com
DiaMedica Therapeutics (NASDAQ:DMAC)
Historical Stock Chart
From Mar 2024 to Apr 2024
DiaMedica Therapeutics (NASDAQ:DMAC)
Historical Stock Chart
From Apr 2023 to Apr 2024